[EN] COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY<br/>[FR] COMPOSÉS ET PROCÉDÉS DE MODULATION DE L'ACTIVITÉ DE CDK9
申请人:KRONOS BIO INC
公开号:WO2022098843A1
公开(公告)日:2022-05-12
Provided are heterobifunctional degrader compounds that bind with cyclin dependent kinase 9 (CDK9) and E3 ubiquitin ligase. Also provided are methods of treating a subject for a CDK9-mediated disease by administering a therapeutically effective dose of a pharmaceutical composition including the heterobifunctional degrader.
提供的是异双功能降解化合物,它们与细胞周期依赖性激酶9(CDK9)和E3泛素连接酶结合。同时,提供了一种通过给予含有异双功能降解剂的药物组合物的治疗方法,用于治疗CDK9介导的疾病。